Clinical Profile of Hypertension in Diabetes Mellitus Patients at Surya Melati Muhammadiyah Hospital, Kediri, in 2021
Downloads
Highlights:
- This study presented the clinical profile of hypertension in patients with DM, providing regional data not previously reported in the literature. It emphasizes the value of implementing targeted interventions.
- Discussion of pathophysiological mechanisms explained the link between DM and hypertension.
Abstract
Introduction: The cardiologic and vascular consequences of both diabetes mellitus (DM) and hypertension often occur side by side in a high incidence worldwide. They are primarily caused by the significant overlap of microvascular and macrovascular aberrations, as well as several other factors, making them closely related to one another. A better understanding between these two is needed. This study examined the clinical profile of hypertension in DM patients at Surya Melati Muhammadiyah Hospital, Kediri, in 2021.
Methods: This study employed an observational, descriptive design. The population of the study was patients with DM and hypertension treated at Surya Melati Muhammadiyah Hospital, Kediri, in 2021. This study used a total sampling method. Diabetes mellitus, hypertension, age, and gender were the observed variables. All the necessary data were obtained from the patients’ medical records. All statistical data analyses were conducted using Microsoft Excel.
Results: A total of 520 DM patients were included, comprising 185 males and 335 females. Most of them were between 51 and 60 years old, with a total of 233 patients. A total of 277 DM patients with hypertension were included, comprising 89 males and 188 females. Most of them were between 51 and 60 years old, with a total of 121 patients.
Conclusion: The number of diabetes mellitus patients with hypertension exceeded that of diabetes mellitus patients without hypertension. There were more female patients than males. Most of them were elderly.
Iqbal AM, Jamal SF. Essential Hypertension. Treasure Island (FL), 2025. [PubMed]
Gabb G. What is Hypertension? Australian Prescriber 2020; 43: 108–109. [PubMed]
Mills KT, Stefanescu A, He J. The Global Epidemiology of Hypertension. Nat Rev Nephrol 2020; 16: 223–237. [Journal]
Princewel F, Cumber SN, Kimbi JA, Nkfusai CN, Keka EI, Viyoff VZ, et al. Prevalence and Risk Factors Associated with Hypertension among Adults in a Rural Setting: The Case of Ombe, Cameroon. Pan Afr Med J 2019; 34: 147. [PubMed]
Paczkowska A, Hoffmann K, Kus K, Kopciuch D, Zaprutko T, Ratajczak P, et al. Impact of Patient Knowledge on Hypertension Treatment Adherence and Efficacy: A Single-Centre Study in Poland. Int J Med Sci 2021; 18: 852–860. [PubMed]
Sapra A, Bhandari P. Diabetes. Treasure Island (FL), 2025. [PubMed]
Dewi GAAIK, Wibisono S, Pawana IPA. Risk Factors for Lower Extremity Amputation in Diabetic Foot Ulcer Patients: A Case-Control Study. JUXTA J Ilm Mhs Kedokt Univ Airlangga 2020; 11: 83–85. [Journal]
International Diabetes Federation (IDF). IDF Diabetes Atlas. Brussels, (2021). [Website]
Ismail L, Materwala H, Al Kaabi J. Association of Risk Factors with Type 2 Diabetes: A Systematic Review. Comput Struct Biotechnol J 2021; 19: 1759–1785. [ScienceDirect]
Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, Regional, and National Burden and Trend of Fiabetes in 195 Countries and Territories: An Analysis from 1990 to 2025. Sci Rep 2020; 10: 14790. [Journal]
Moien ABK, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi JA. Epidemiology of Type 2 Diabetes — Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health 2020; 10: 107–111. [Springer]
Goyal R, Singhal M, Jialal I. Type 2 Diabetes. Treasure Island (FL), 2025. [PubMed]
Sari Y, Isworo A, Upoyo AS, Taufik A, Setiyani R, Swasti KG, et al. The Differences in Health-Related Quality of Life between Younger and Older Adults and Its Associated Factors in Patients with Type 2 Diabetes Mellitus in Indonesia. Health Qual Life Outcomes 2021; 19: 124. [Journal]
Pangribowo S. Beban Kanker di Indonesia. Jakarta, (2019). [Website]
Hung MJ. Diabetes, Hypertension and Cardiovascular Disease: Clinical Insights, Mechanisms and Pharmacotherapies. Medicina; 60. 2024. [Journal]
Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension 2021; 78: 1197–1205. [Journal]
Gates B, Allen P. Excel, (2021). [Website]
Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JE. Sex Differences in the Burden of Type 2 Diabetes and Cardiovascular Risk across the Life Course. Diabetologia 2019; 62: 1761–1772. [Springer]
Ong C. Characteristic of Chronic Complications in Type 2 Diabetic Patient based on Asian Perspective. Curr Intern Med Res Pract Surabaya J 2022; 3: 13–15. [Journal]
Naha S, Gardner MJ, Khangura D, et al. Hypertension in Diabetes. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al. (eds). South Dartmouth (MA), 2000. [PubMed]
Ghorani HA, Götzinger F, Böhm M, Mahfoud F. Arterial Hypertension – Clinical Trials Update 2021. Nutr Metab Cardiovasc Dis 2022; 32: 21–31. [ScienceDirect]
Miftahussurur M, Roostarini JW, Soelistijo SA, Novida H, Sutjahjo A, Wibisono S, et al. Lipoprotein (A) and Arterial Stiffness in Patients with Diabetes Mellitus. New Armen Med J 2019; 13: 74–78. [ResearchGate]
Sutadji JT, Pranoto A, Prasetyo RV. Risk Factors of Chronic Kidney Disease (CKD) in Type 2 Diabetes Mellitus (DM) Patients at Dr. Soetomo General Academic Hospital, Surabaya. JUXTA J Ilm Mhs Kedokt Univ Airlangga 2023; 14: 12–16. [Journal]
Melasari WP, Suharjono S, Samsulhadi W. Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-Alpha on Diabetes Patient with Dyslipidemia. Folia Medica Indones 2021; 57: 6–10. [Journal]
Copyright (c) 2025 Ahmad Zaidan Ni'am Abu Adha, Fahmi Adi Priyantoro

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).